Erschienen in:
01.11.2009 | Case Report
Psoriatic arthritis and chronic lymphoedema: treatment efficacy by adalimumab
verfasst von:
Denise Tong, Sharron Eather, Nicholas Manolios
Erschienen in:
Clinical Rheumatology
|
Ausgabe 11/2009
Einloggen, um Zugang zu erhalten
Abstract
Lymphoedema is a rare complication of psoriatic arthritis (PsA) and inflammatory joint disease, with no response noted to disease-modifying drugs. However, reports are emerging of a beneficial effect on lymphoedema in patients treated with tumor necrosis factor-alpha antagonists for PsA (Etanercept), rheumatoid arthritis (Etanercept) and ankylosing spondylitis (Infliximab). We describe a psoriatic arthritis patient whose lymphoedema greatly improved following commencement of adalimumab.